Browse All

Current Filters

CLEAR FILTER x

TITLE

Program Number:

Suppression of eEF2 Phosphorylation Alleviates Synaptic Failure and Cognitive Deficits in Mouse Models of Down Syndrome

A Comprehensive Review of Novel FDA-approved Neurological Indications from 2018-2023

Immunomonitoring of Intravenous and Subcutaneous Anti-CD49d Treatment in Patients with Multiple Sclerosis